Viveon Health Acquisition... (VHAQ)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
10.00
null (null%)
At close: Jan 14, 2025, 8:00 PM
Company Description
Viveon Health Acquisition Corp. does not have significant operations.
It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses in the healthcare industry in North America.
The company was incorporated in 2020 and is based in Norcross, Georgia.
Viveon Health Acquisition Corp.
Country | United States |
IPO Date | Feb 4, 2021 |
Industry | Shell Companies |
Sector | Financial Services |
Employees | n/a |
CEO | Dr. Jagi Gill M.D., Ph.D. |
Contact Details
Address: Spalding Exchange Norcross, Georgia United States | |
Website | n/a |
Stock Details
Ticker Symbol | VHAQ |
Exchange | AMEX |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001823857 |
CUSIP Number | 92853V106 |
ISIN Number | US92853V1061 |
Employer ID | 00-0000000 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Dr. Jagi Gill M.D., Ph.D. | Chief Executive Officer, President & Chairman of the Board |
Dr. Romilos Papadopoulos M.D. | Chief Financial Officer, Treasurer, Secretary & Director |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Oct 04, 2024 | 8-K | Current Report |
Jul 19, 2024 | 425 | Filing |
Jul 19, 2024 | 8-K | Current Report |
Jul 10, 2024 | 25-NSE | Filing |
Jun 06, 2024 | 10-Q | Quarterly Report |
Jun 05, 2024 | 425 | Filing |
Jun 05, 2024 | 8-K | Current Report |
May 30, 2024 | NT 10-Q | Filing |
Apr 01, 2024 | 425 | Filing |